Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection

Lancet

Volumn 363, Issue 9407, 2004, Pages 422-428

  Herzog, C ^a   Sales N ^a   Etchegaray, N ^a   Charbonnier, A ^a   Freire, S ^a   Dormont, D ^a   Deslys, J P ^a   Lasmezas C I ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN; PRION PROTEIN; PRION PROTEIN, BOVINE SPONGIFORM ENCEPHALOPATHY;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN; BRAIN HOMOGENATE; BRAIN INFECTION; BRAIN LEVEL; BRAIN TISSUE; BRAIN TRANSPLANTATION; CATTLE; CHEMISTRY; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE INNERVATION; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LYMPHOID TISSUE; MACACA; METABOLISM; METHODOLOGY; NERVOUS TISSUE; NEUROLOGIC DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL NERVE; PEYER PATCH; PRIMATE; PRION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECTUM; SPLEEN; TISSUE DISTRIBUTION; TONSIL;

EID: 1142273439     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15487-1     Document Type: Article

References (23)

1. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of Creutfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
2. Lasmézas C.I., Deslys J-P, Robain O., et al. BSE transmission to macaques. Nature. 381:1996;743-744.
3. Collinge J., Sidle K.C.L., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature. 383:1996;685-690.
4. Bruce M.E., Will R.G., Ironside J.W., et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature. 389:1997;498-501.
5. Brown P., Gibbs C.J., Rodgers-Johnson P., et al. Human spongiform encephalopathy: the NIH series of 300 cases of experimentally transmitted disease. Ann Neurol. 35:1994;513-529.
6. Glatzel M., Abela E., Maissen M., Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med. 349:2003;1812-1820.
7. Bruce M.E., McConnell I., Will R.G., Ironside J.W. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet. 358:2001;208-209.
8. Hill A.F., Butterworth R.J., Joiner S., et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 353:1999;183-189.
9. Head M.W., Ritchie D., Smith N., et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol. 164:2004;143-153.
10. Ironside J.W., Head M.W. Variant Creutzfeldt-Jakob disease and its transmission by blood. J Thromb Haemost. 1:2003;1479-1486.
11. van Duijn C.M., Delasnerie-Laupretre N., Masullo C., et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet. 351:1998;1081-1085.
12. Llewelyn C.A., Hewitt P.E., Knight R.S.G., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 363:2004;417-421.
13. Kimberlin R.H., Walker C.A. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol. 89:1979;551-562.
14. Maignien T., Lasmézas C.I., Beringue V., Dormont D., Deslys J-P. Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents. J Gen Virol. 80:1999;3035-3042.
15. Hunter N., Foster J., Chong A., et al. Transmission of prion diseases by blood transfusion. J Gen Virol. 83:2002;2897-2905.
16. Lasmézas C.I., Fournier J-G, Nouvel V., et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci USA. 98:2001;4142-4147.
17. Thomzig A., Kratzel C., Lenz G., Kruger D., Beekes M. Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep. 4:2003;530-533.
18. Lasmézas C.I., Deslys J-P, Robain O., et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science. 275:1997;402-405.
19. Deslys J.P., Comoy E., Hawkins S., et al. Screening slaughtered cattle for BSE. Nature. 409:2001;476-478.
20. Giaccone G., Canciani B., Puoti G., et al. Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. Brain Pathol. 10:2000;31-37.
21. Schulz-Schaeffer W.J., Tschoke S., Kranefuss N., et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol. 156:2000;51-56.
22. Cervenakova L., Yakovleva O., McKenzie C., et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion. 43:2003;1687-1694.
23. Wadsworth J.D., Joiner S., Hill A.F., et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. 358:2001;171-180.